Human lymphoblastoid cells transiently expressing the hemagglutinin (HA) glycoprotein of influenza virus are rapidly and efficiently recognized by CD4+ HA-specific T lymphocytes. This endogenous presentation pathway is sensitive to chloroquine and is therefore likely related to the classical class II major histocompatibility complex (MHC) exogenous pathway of antigen presentation. In this study we have examined a series of transport-defective HA mutants. We correlate the intracellular fate of the native antigen with its presentation characteristics. We have found that the native antigen must enter the secretory pathway since a cytosolic form is not presented. However, surface expression and normal trafficking through the Golgi apparatus are not required for efficient presentation. Instead, escape of native antigen from the endoplasmic reticulum appears to be both necessary and sufficient for gaining access to a compartment where antigen is processed and binds class II MHC molecules.
Skip Nav Destination
Article navigation
1 April 1993
Article|
April 01 1993
Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.
D J Kittlesen,
D J Kittlesen
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Search for other works by this author on:
L R Brown,
L R Brown
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Search for other works by this author on:
V L Braciale,
V L Braciale
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Search for other works by this author on:
J P Sambrook,
J P Sambrook
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Search for other works by this author on:
M J Gething,
M J Gething
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Search for other works by this author on:
T J Braciale
T J Braciale
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Search for other works by this author on:
D J Kittlesen
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
L R Brown
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
V L Braciale
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
J P Sambrook
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
M J Gething
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
T J Braciale
Beirne B. Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville 22908.
Online ISSN: 1540-9538
Print ISSN: 0022-1007
J Exp Med (1993) 177 (4): 1021–1030.
Citation
D J Kittlesen, L R Brown, V L Braciale, J P Sambrook, M J Gething, T J Braciale; Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants.. J Exp Med 1 April 1993; 177 (4): 1021–1030. doi: https://doi.org/10.1084/jem.177.4.1021
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement